1. |
Ichikura T, Ogawa T, Chochi K, et al. Minimum number of lymph nodes that should be examined for the International Union Against Cancer/American Joint Committee on Cancer TNM classification of gastric carcinoma [J]. World J Surg, 2003; 27(3)∶330.
|
2. |
Kikuchi S, Katada N, Sakuramoto S, et al. Factors associated with pN3 stage tumors according to the TNM classification in advanced gastric cancer [J]. Hepatogastroenterology, 2003; 50(53)∶1723.
|
3. |
Nitti D, Marchet A, Olivieri M, et al. Lymphadenectomy in patients with gastric cancer. A critical review [J]. Suppl Tumori, 2003; 2(5)∶S35.
|
4. |
Roviello F, Marrelli D, Morgagni P, et al. Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study [J]. Ann Surg Oncol, 2002; 9(9)∶894.
|
5. |
Edwards P, Blackshaw GR, Lewis WG, et al. Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma [J]. Br J Cancer, 2004; 90(10)∶1888.
|
6. |
Verreet PR. Stageadapted radical principles in gastric carcinoma [J]. Schweiz Rundsch Med Prax, 1998; 87(13)∶447.
|
7. |
Roviello F, Marrelli D, Morgagni P, et al. Benefits of extended lymphadenectomy in patients with gastric carcinoma with metastasis to second level lymph nodes. An Italian multicenter study [J]. Chir Ital, 2003; 55(4)∶491.
|
8. |
Ikeguchi M, Oka S, Gomyo Y, et al. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer [J]. Anticancer Res, 2000; 20(2B)∶1285.
|
9. |
Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial [J]. J Clin Oncol, 2004; 22(11)∶2069.
|
10. |
Maruyama K, Sasako M, Kinoshita T, et al. Reasonable lymph node dissection in radical gastrectomy for gastric cancer: introduction of computer information system and lymphography technique by Indiaink [J]. Nippon Geka Gakkai Zasshi, 1989; 90(9)∶1318.
|
11. |
Maruyama K, Gunven P, Okabayashi K, et al. Lymph node metastases of gastric cancer. General pattern in 1 931 patients [J]. Ann Surg, 1989; 210(5)∶596.
|
12. |
Omejc M, Mekicar J. Role of computer analysis in gastric cancer surgery: evaluation of the WinEstimate v. 2.5 computer program [J]. World J Surg, 2004; 28(1)∶59.
|
13. |
Ohta K, Nishi M, Nakajima T, et al. Indications for total gastrectomy combined with pancreaticosplenectomy in the treatment of middle gastric cancer [J]. Nippon Geka Gakkai Zasshi, 1989; 90(9)∶1326.
|
14. |
Kikuchi S, Nemoto Y, Natsuya K, et al. Which patients with advanced, proximal gastric cancer benefit from complete clearance of splenopancreatic lymph nodes? [J]. Anticancer Res, 2002; 22(6B)∶3513.
|
15. |
Marrelli D, Roviello F, de Manzoni G, et al. Different patterns of recurrence in gastric cancer depending on Lauren’s histological type: longitudinal study [J]. World J Surg, 2002; 26(9)∶1160.
|
16. |
Shiraishi N, Inomata M, Osawa N, et al. Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses [J]. Cancer, 2000; 89(2)∶255.
|
17. |
Funami Y, Tokumoto N, Miyauchi H, et al. Prognostic value of peritoneal lavage cytology and chemotherapy during surgery for advanced gastric cancer [J]. Int Surg, 1999; 84(3)∶220.
|
18. |
Sethna KS, Sugarbaker PH. New prospects for the control of peritoneal surface dissemination of gastric cancer using perioperative intraperitoneal chemotherapy [J]. Cancer Therapy, 2004; 2(A)∶79.
|
19. |
Marutsuka T, Shimada S, Shiomori K, et al. Mechanisms of peritoneal metastasis after operation for nonserosainvasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis [J]. Clin Cancer Res, 2003; 9(2)∶678.
|
20. |
Yonemura Y, de Aretxabala X, Fujimura T, et al. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study [J]. Hepatogastroenterology, 2001; 48(42)∶1776.
|
21. |
梁寒, 王仆, 王晓娜, 等. 活性碳吸附丝裂霉素C腹腔化疗预防进展期胃癌术后复发 [J]. 中华外科杂志, 2003; 41(4)∶274.
|
22. |
Newman E, Marcus SG, Potmesil M, et al. Neoadjuvant chemotherapy with CPT11 and cisplatin downstages locally advanced gastric cancer [J]. J Gastrointest Surg, 2002; 6(2)∶212.
|
23. |
Ajani JA, Mansfield PF, Janjan N, et al. Multiinstitutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma [J]. J Clin Oncol, 2004; 22(14)∶2774.
|
24. |
Kim JP, Yu HJ, Lee JH. Results of immunochemosurgery for gastric carcinoma [J]. Hepatogastroenterology, 2001; 48(41)∶1227.
|
25. |
Nakahara S, Tsunoda T, Baba T, et al. Dendritic cells stimulated with a bacterial product, OK432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptide [J]. Cancer Res, 2003; 63(14)∶4112.
|
26. |
Kono K, Takahashi A, Ichihara F, et al. Prognostic significance of adoptive immunotherapy with tumorassociated lymphocytes in patients with advanced gastric cancer: a randomized trial [J]. Clin Cancer Res, 2002; 8(6)∶1767.
|
27. |
Kono K, Takahashi A, Sugai H, et al. Dendritic cells pulsed with HER2/neuderived peptides can induce specific Tcell responses in patients with gastric cancer [J]. Clin Cancer Res, 2002; 8(11)∶3394.
|